Twin Presentations Position Merck, GSK PD-1 Inhibitors As Endometrial Cancer Rivals

 
• By Alaric DeArment
  
Merck presented data from a Phase III trial of Keytruda in endometrial cancer • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business